Can IGF-1 LR3 cause hypoglycemia, and how do I prevent it
Those with liver or kidney disease should also use caution
Protocol approach 2: gut-focused autoimmune support (BPC-157 plus KPV) Goal: Restore gut barrier integrity and reduce intestinal inflammation Components: BPC-157 : 200-300 mcg twice daily, orally or subcutaneously near the abdomen (promotes mucosal healing, angiogenesis) KPV: 200-500 mcg daily, orally (NF-kB inhibition, cytokine reduction, PepT1-mediated gut absorption) Rationale: For autoimmune conditions with significant gastrointestinal involvement, including IBD, celiac-associated inflammation, or any autoimmune condition complicated by leaky gut, this combination addresses both the physical barrier damage (BPC-157) and the inflammatory signaling (KPV)
Weight loss timelines vary widely depending on starting dose, genetics, and lifestyle factors
As always, maintaining open communication with your healthcare providers and insurers and staying informed about changes in health policies will aid in this journey toward better health and well-being
& Saitoh, Y
